Home > Products > gp40 & TFRC > Anti-gp40 x Anti-TFRC Bispecific Antibody (IgG-IgG)

Anti-gp40 x Anti-TFRC Bispecific Antibody (IgG-IgG)  (BSIG-164)

Anti-gp40 x Anti-TFRC Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-gp40 and anti-TFRC parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can bind two tumor antigens simultaneously. It is designed for the research of Colon cancer; Ovarian cancer therapy.

Datasheet
Specifications
Targets
gp40 & TFRC
Type
IgG-IgG
Species Reactivity
Human
Target 1
gp40
Host Animal 1
Mouse
Target 2
TFRC
Host Animal 2
Mouse
Application
FuncS; Promising therapeutic agent
Related Disease
Colon cancer; Ovarian cancer
Targets
Target 1
gp40
Alternative Names
gp40; glycoprotein 40; adenocarcinoma-associated antigen
Target 2
TFRC
Gene ID
7037
UniProt ID
P02786
Alternative Names
TFRC; transferrin receptor; T9; TR; TFR; p90; CD71; TFR1; TRFR; transferrin receptor protein 1; transferrin receptor (p90, CD71); IMD46
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Welcome! For price inquiries, we will get back to you as soon as possible.

To order, please email

INQUIRY
Online Inquiry
USA
45-1 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-381-2994
Fax: 1-631-207-8356
Email:

UK
167-169 Great Portland Street, 5th Floor, London, W1W 5PE
Tel: 44-207-097-1828
Email:
Related products of "gp40 & TFRC"
24x7 CUSTOMER SERVICE
Easy access to products and services you need from our library via
powerful searching tools
© 2021 Creative-Biolabs All Rights Reserved. Distributors
To view the contact information for a specific location,
select your country or region: